Indeed, Lrg1 deletion was found to be protective against DKD as Lrg1−/− streptozotocin (STZ)-induced diabetic mice show milder angiogenesis, reduced podocyte foot process effacement and significantly improved kidney function. This evidence concerns the gene LRG1 and diabetic kidney disease.